8 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Diabetes Reversing Implants with enhanced Viability and long-term Efficacy (DRIVE)
Date du début: 1 juin 2015, Date de fin: 31 mai 2019,
Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance which affects 382 million people worldwide. Pancreatic islet transplantation is an extremely promising cure for insulin-sensitive diabetes mellitus (ISDM), but side effects of lifelong systemic immunosuppressive therapy, short supply of donor islets and their po ...
Voir le projet
14
Participants partenaires
TERMINÉ
Living Architecture (LIAR)
Date du début: 1 avr. 2016, Date de fin: 31 mars 2019,
Living Architecture (LIAR) is a modular bioreactor-wall, which is based on the operational principles of microbial fuel cell technology and synthetic ‘consortia’ of microbes. LIAR is conceived as a next-generation selectively-programmable bioreactor and integral component of human dwelling, capable of extracting valuable resources from waste water and air, generation of oxygen and production of p ...
Voir le projet
7
Participants partenaires
TERMINÉ
Advanced Materials for Cardiac Regeneration (AMCARE) (AMCARE)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,
The Advanced Materials for Cardiac Regeneration (AMCARE) consortium aims to establish a translational research program to develop truly restorative therapies for acute myocardial infarction repair (MI) by optimising cardiac progenitor cell (CPC) therapy using smart biomaterials and advanced drug delivery, and coupling these therapeutics with minimally-invasive surgical devices. Two distinct biomat ...
Voir le projet
10
Participants partenaires
TERMINÉ
"Nano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts." (NEXT)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
"Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately evolves into in complications which alter patients integrity and wellness. Treatment is based on lifetime drugs administration for blood glucose control or parenteral infusion of insulin to better control glucose levels and glycosylation of hemoglobin. Artifici ...
Voir le projet
6
Participants partenaires
TERMINÉ
Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients (TOPCAPI)
Date de fin: 1 janv. 2017,
TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE2270, a starter compound for the semi-synthesis of NAI-Acne, a new topical anti-acne drug in Phase II clinical trials; 6-desmethyl-tetracycline (6DM-TC) and 6-desmethyl 6-deshydro tetracycline (6DM6DH-TC), intermediates for semi-synthetic conversion to medically ...
Voir le projet
8
Participants partenaires
TERMINÉ
Tissue in Host Engineering Guided Regeneration of Arterial Intimal Layer (THE GRAIL)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
"The concept of THE GRAIL project is the creation of an in vivo, in situ structured bioactive, selectively porous, bioresorbable scaffold that locally regenerates intima growth after endovascular treatment of the obstructed arteries in patients with atherosclerosis. Arterial obstruction due to arteriosclerosis is the cause of a wide spectrum of diseases, disabilities and death, because of induced ...
Voir le projet
9
Participants partenaires
TERMINÉ
Magnetic Scaffolds for in vivo Tissue Engineering (MAGISTER)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2012,
The main driving idea of the project is the creation of conceptually new type of scaffolds able to be manipulated in situ by means of magnetic forces. This approach is expected to generate scaffolds with such characteristics as multiple use and possibly multipurpose delivery in order to repair large bone defects and ostheocondral lesions in the articular surface of the skeletal system. The major ...
Voir le projet
21
Participants partenaires
TERMINÉ
BIOETHANOL PRODUCTION VIA LIGNOCELLULOSIC FERMENTATION OF OLIVE OIL RESIDUES (ETOILE)
Date du début: 1 nov. 2008, Date de fin: 31 janv. 2011,
"Bioethanol has been increasingly becoming the renewable energy source that could reduce the oil dependence of the developed countries. Biorefineries can use the locally grown agriculture to produce ethanol. However, food chain supply is beginning to suffer the effects of the ethanol massive production raising major ethical concerns. Cellulosic ethanol can overcome the environmental risks that acc ...
Voir le projet